Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 97,108 | 105,659 | 71,962 | 69,157 | 67,689 |
| Operating Income | -97,108 | -105,659 | -71,962 | -69,157 | -67,689 |
| Other Income | 7,566 | 8,534 | 6,860 | 3,508 | 1,051 |
| Pre-tax Income | -89,542 | -97,125 | -65,102 | -65,649 | -66,638 |
| Net Income Continuous | -89,542 | -97,125 | -65,102 | -65,649 | -66,638 |
| Net Income | $-89,542 | $-97,125 | $-65,102 | $-65,649 | $-66,638 |
| EPS Basic Total Ops | -0.90 | -0.96 | -0.70 | -0.81 | -1.10 |
| EPS Basic Continuous Ops | -0.90 | -0.96 | -0.70 | -0.81 | -1.10 |
| EPS Diluted Total Ops | -0.90 | -0.96 | -0.70 | -0.81 | -1.10 |
| EPS Diluted Continuous Ops | -0.90 | -0.96 | -0.70 | -0.81 | -1.10 |
| EPS Diluted Before Non-Recurring Items | -0.88 | -0.96 | -0.70 | N/A | N/A |
| EBITDA(a) | $-97,494 | $-106,197 | $-72,832 | $-69,294 | $-67,484 |